吸烟与三叉神经痛:微血管减压术前的临床特征及术后结局
研究基于前瞻性登记数据库的171例接受微血管减压术的经典三叉神经痛患者,按术前6个月内是否吸烟分为吸烟组与非吸烟组。吸烟组患者更年轻(53岁 vs 62岁,P<.01),疼痛累及单一三叉神经分布区的比例更低(36% vs 65%,P<.01)。在随访至少6个月的128例患者中,吸烟组末次随访时停药无痛的比例显著更低(36% vs 57%,P<.05)。
要点
- 吸烟的三叉神经痛患者接受微血管减压术时年龄更轻(53岁 vs 62岁,P<.01)。
- 吸烟组疼痛累及单一三叉神经分布区的比例低于非吸烟组(36% vs 65%,P<.01)。
- 随访至少6个月者中,吸烟组末次随访停药无痛比例低于非吸烟组(36% vs 57%,P<.05)。
核心结论
- 在接受微血管减压术的三叉神经痛患者中,吸烟与更年轻的三叉神经痛发病年龄、更广泛的面部疼痛及更差的微血管减压术后长期结局相关。
- 作者认为这些特征提示吸烟者的三叉神经痛可能代表一种更严重的疾病形式,对治疗的反应不同于非吸烟者。
研究设计与样本
- 数据来自前瞻性维护的登记数据库,纳入171例接受微血管减压术治疗的经典三叉神经痛患者。
- 根据术前6个月内是否使用烟草将患者分为吸烟者与非吸烟者,分析临床特征与术后结局。
主要发现
- 与非吸烟的三叉神经痛患者相比,使用烟草的微血管减压术患者显著更年轻(53岁 vs 62岁,P<.01)。
- 吸烟组报告疼痛位于单一三叉神经分布区的比例显著低于非吸烟组(36% vs 65%,P<.01)。
- 吸烟者与非吸烟者在存在某种程度的持续性疼痛、神经血管压迫严重程度、性别、种族、肥胖、就诊前疼痛持续时间、术后即刻结局、住院时间及术后并发症方面无差异。
- 在随访至少6个月的128例患者中,吸烟组末次随访时停药无痛的比例显著低于非吸烟组(36% vs 57%,P<.05)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Tobacco use is known to affect incidence and postoperative outcome for several neurosurgical disorders, but its relationship to trigeminal neuralgia (TN) is not known. We sought to identify unique population characteristics that correlate with tobacco use in a cohort of patients with TN who underwent microvascular decompression (MVD), including effect on long-term postoperative outcome. METHODS: Data about 171 patients with classic TN treated with MVD were obtained from a prospectively maintained registry. Patients were classified as smokers or nonsmokers based on the use of tobacco within the 6 months before surgery. Analysis of clinical characteristics and postoperative outcome was performed. RESULTS: Compared with nonsmokers with TN, MVD patients using tobacco were significantly younger (53 vs 62 years, P < .01) and less likely to report pain in a single distribution of the trigeminal nerve (36% vs 65%, P < .01). There was no difference between smokers and nonsmokers in the presence of some degree of continuous pain, severity of neurovascular compression, sex, race, obesity, pain duration before presentation, immediate postoperative outcome, length of stay, or postoperative complication profile. Among 128 patients followed for at least 6 months, smokers were significantly less likely to be pain-free off medications at the last follow-up (36% vs 57%, P < .05). CONCLUSION: In patients undergoing MVD for TN, smoking is associated with younger age of TN onset, more widespread facial pain, and worse long-term postoperative outcome after MVD. These features suggest that TN in smokers may represent a more severe disease form compared with TN in nonsmokers with different responses to treatment.
引用
- Shepherd J, Li S, Herring E, et al. Tobacco Use and Trigeminal Neuralgia: Clinical Features and Outcome After Microvascular Decompression. Neurosurgery. 2024. PMID: 39324787. doi:10.1227/neu.0000000000003192
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。